Atlas Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.

Clinical trial NCT04429282 · UNKNOWN

Trial details

NCT number
NCT04429282
Sponsor
Yi Feng, MD
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
IbuprofenNonsteroidal Anti-inflammatory DrugIntravenousInjectablePainAnalgesic
Start date
2020-06-10
Primary completion
2020-06-10
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.